Business Description
ISIN : US1314281049
Total Employee Number:
1,540Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | -0.41 | |||||
Debt-to-Equity | -1.99 | |||||
Debt-to-EBITDA | 728.61 | |||||
Interest Coverage | 0.26 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.26 | |||||
Beneish M-Score | -3.1 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.9 | |||||
3-Year EBITDA Growth Rate | 27.8 | |||||
3-Year EPS without NRI Growth Rate | 16.2 | |||||
3-Year Book Growth Rate | -7.8 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.22 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 78.39 | |||||
9-Day RSI | 71.69 | |||||
14-Day RSI | 68.66 | |||||
3-1 Month Momentum % | 11.21 | |||||
6-1 Month Momentum % | 29.87 | |||||
12-1 Month Momentum % | 128.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.84 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 33.12 | |||||
Days Sales Outstanding | 24.4 | |||||
Days Payable | 26.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | -1.52 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 6.57 | |||||
Operating Margin % | 1.19 | |||||
Net Margin % | -2.98 | |||||
EBITDA Margin % | 0.07 | |||||
FCF Margin % | 1.6 | |||||
OCF Margin % | 3.18 | |||||
ROA % | -4.97 | |||||
ROIC % | 1.15 | |||||
3-Year ROIIC % | 26.17 | |||||
ROC (Joel Greenblatt) % | -4.46 | |||||
ROCE % | -3.67 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 24.77 | |||||
PS Ratio | 1.02 | |||||
Price-to-Free-Cash-Flow | 64.33 | |||||
Price-to-Operating-Cash-Flow | 32.36 | |||||
EV-to-EBIT | -111.01 | |||||
EV-to-Forward-EBIT | 20.52 | |||||
EV-to-EBITDA | 2309.7 | |||||
EV-to-Forward-EBITDA | 13.97 | |||||
EV-to-Revenue | 1.56 | |||||
EV-to-Forward-Revenue | 1.26 | |||||
EV-to-FCF | 97.42 | |||||
Price-to-GF-Value | 2.95 | |||||
Price-to-Median-PS-Value | 4.56 | |||||
Earnings Yield (Greenblatt) % | -0.9 | |||||
FCF Yield % | 1.54 | |||||
Forward Rate of Return (Yacktman) % | -19.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CLMT
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Calumet Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,591.4 | ||
| EPS (TTM) ($) | -1.55 | ||
| Beta | 0.7534 | ||
| 3-Year Sharpe Ratio | 0.83 | ||
| 3-Year Sortino Ratio | 1.46 | ||
| Volatility % | 39.58 | ||
| 14-Day RSI | 68.66 | ||
| 14-Day ATR ($) | 2.243336 | ||
| 20-Day SMA ($) | 49.2955 | ||
| 12-1 Month Momentum % | 128.6 | ||
| 52-Week Range ($) | 17.08 - 54.75 | ||
| Shares Outstanding (Mil) | 87.9 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Calumet Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Calumet Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-26 09:00 | In 171 days | ||
| Annual report for 2026 | 2027-02-26 | In 170 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-26 | In 170 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 09:00 | In 59 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 58 days | ||
| Barclays 40th Annual Energy-Power Conference | 2026-09-10 | In 1 day | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 09:00 | 41.88 (+1.55%) | ||
| Second quarter earnings results for 2026 | 2026-08-07 | 41.88 (+1.55%) | ||
| Bank of America Energy and Power Credit Conference | 2026-06-04 | 37.37 (+1.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-08 09:00 | 34.61 (+2.28%) |
Calumet Inc Frequently Asked Questions
Guru Commentaries on NAS:CLMT
Calumet Inc was the only material long detractor in the period, declining by -0.9%. The company has made progress by finalizing its Department of Energy loan and completing the disposal of a non-core asset to deleverage. Following a regulatory change to subsidies for renewable diesel in 2025, US renewable diesel output has collapsed, which has triggered a recovery in the market for D4 RIN credits. D4 RINs are now trading at the highest prices in two years, which is favorable for the economics of Calumet’s biorefinery operation. The position was reduced during the quarter as the balance sheet risk was reassessed, but the manager continues to see a strong risk-reward, albeit with a wide range of outcomes.
We exited our equity position in Calumet Specialty Products early in the quarter in the low 20s, despite seeing a clear line of sight to well over $30/share in near-term intrinsic value. The exit was driven by management's failure to execute and communicate effectively, which we believe is critical for realizing the company's potential. Although non-core asset sales are complete and the ATM is out of the picture, management's inability to credibly detail contracted offtake agreements for SAF at a premium to renewable diesel has left investors confused. We still see a credible path to a re-rate into the upper $20s, contingent on favorable industry conditions.
Press Release
Articles on Calumet Inc
Headlines
See More- 1
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
